The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Joimax sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Joimax is a medical equipment company that develops, manufactures and markets complete systems for endoscopic minimally invasive spinal surgery. The company offers innovative technologies, systems, and methods for endoscopic minimally invasive spinal surgery. Its major products include Endoscopic Surgical Systems TESSYS (transforaminal), iLESSYS (interlaminar) and CESSYS (cervical) for decompression procedures, MultiZYTE for facet and sacroiliac joint pain treatment and EndoLIF and Percusys for minimally invasive endoscopically assisted stabilizations, established systems are provided, addressing a whole range of indications. Also, its smart electromagnetic Navigation system Intracs ensures easy and safe access to any spinal target. Joimax is headquartered in Irvine, California, the US.
The key metrics of Joimax related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Joimax is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Joimax.
For a detailed understanding of the performance of Joimax, buy the report here.